Bli medlem
Bli medlem

Du är här


Vitrolife AB (publ): Conference call interim report

Invitation to attend Vitrolife's conference call regarding
presentation of the interim report for the period January - September
2016. The presentation will be held in English.

Time: Thursday November 3, 2016 at 10.00 a.m. CET.

Registration can preferably be done 10-15 minutes before the
conference start time on:

Sweden dial in number: +46 (0)8 5052 0114

UK dial in number: +44 (0)207 1620 177

Conference name: Vitrolife, conference ID: 960496

Vitrolife participants:
Thomas Axelsson, CEO

Mikael Engblom, CFO
The press release for Vitrolife's interim report will be released at
8.30 CET on the same day.

Before the conference call, slides will be available at the company
web page,

A recorded version of the presentation will be available for seven
days on number

+46 (0)8 5052 0333 (Sweden) or 020 7031 4064 (UK), access code 960496.

Gothenburg, July 7, 2016


For further information, please contact:
Mikael Engblom, CFO, 46 (0) 31 721 80 14

This is a translation of the Swedish version of the press release.
When in doubt, the Swedish wording prevails.


Vitrolife is an international medical device Group. Vitrolife
develops, produces and markets medical devices for assisted
reproduction. Work is also carried out to enable the use and handling
of stem cells for therapeutic purposes

Vitrolife has approximately 360 employees and the company's products
are sold in almost 110 markets. The company is headquartered in
Gothenburg, Sweden, and there are also offices in USA, Australia,
France, Italy, United Kingdom, China, Japan, Hungary, Denmark and
Germany. The Vitrolife share is listed on NASDAQ Stockholm, Mid Cap.

Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate
identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80
99. E-mail: Website:


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.